Type to search

PacBio and Boston Children's Hospital Collaborate to Investigate Novel Variants Inaccessible by Short-Read Sequencing | PTF
BHT Announces Positive Results from Osteopenia Treatment | PTF
Syndax Announces U.S. FDA Breakthrough Therapy Designation Granted for Patients with Relapsed or Refractory KMT2A- Rearranged (MLLr) Acute Leukemia | PTF